Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

JAB1 Promotes High Glucose-Induced Inflammation and Extracellular Matrix Deposition in Glomerular Mesangial Cells by Regulating Angiopoietin-Like Protein 2

P. Zhu, Y. Wu, Y. Gu, C. Li

. 2021 ; 67 (5-6) : 191-198. [pub] -

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22013072

Diabetic or hyperglycaemic conditions stimulate the inflammatory response, excessive accumulation of extracellular matrix, and result in glomerulosclerosis, a scarring process of diabetic nephropathy. c-Jun activation domain-binding protein 1 (JAB1) functions as a regulator of pathways involved in cellular apoptosis and proliferation. The role of JAB1 in diabetic nephropathy was investigated in this study. Firstly, glomerular mesangial cells (GMCs) were treated with high glucose, and high glucose conditions induced up-regulation of JAB1 in the GMCs. Moreover, IL-6, TNF-α, MCP-1, and IL-1β were also elevated in high glucose-induced GMCs. Secondly, silencing of JAB1 reduced the levels of IL-6, TNF-α, MCP-1, and IL-1β in high glucose-induced GMCs. In addition, silencing of JAB1 attenuated the high glucose-induced decrease of superoxide dismutase (SOD) and the increase of reactive oxygen species (ROS) and malondialdehyde (MDA). The increased TGF-β1, collagen I, collagen IV, and fibronectin levels in high glucose-induced GMCs were restored by knockdown of JAB1. Thirdly, angiopoietin-like protein 2 (ANGPTL2) expression was reduced by JAB1. Over-expression of ANGPTL2 weakened the JAB1 silence-induced decrease of IL-6, TNF-α, MCP-1, IL-1β, TGF-β1, collagen I, collagen IV, and fibronectin. In conclusion, silencing of JAB1 reduced extracellular matrix deposition and suppressed inflammation in high glucose-induced GMCs through down-regulation of ANGPTL2.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22013072
003      
CZ-PrNML
005      
20220606152938.0
007      
ta
008      
220504s2021 xr f 000 0|eng||
009      
AR
024    __
$a 10.14712/fb2021067050191 $2 doi
035    __
$a (PubMed)35439852
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Zhu, P. $u Department of General Practice, Shanghai International Medical Center, Shanghai, China
245    10
$a JAB1 Promotes High Glucose-Induced Inflammation and Extracellular Matrix Deposition in Glomerular Mesangial Cells by Regulating Angiopoietin-Like Protein 2 / $c P. Zhu, Y. Wu, Y. Gu, C. Li
520    9_
$a Diabetic or hyperglycaemic conditions stimulate the inflammatory response, excessive accumulation of extracellular matrix, and result in glomerulosclerosis, a scarring process of diabetic nephropathy. c-Jun activation domain-binding protein 1 (JAB1) functions as a regulator of pathways involved in cellular apoptosis and proliferation. The role of JAB1 in diabetic nephropathy was investigated in this study. Firstly, glomerular mesangial cells (GMCs) were treated with high glucose, and high glucose conditions induced up-regulation of JAB1 in the GMCs. Moreover, IL-6, TNF-α, MCP-1, and IL-1β were also elevated in high glucose-induced GMCs. Secondly, silencing of JAB1 reduced the levels of IL-6, TNF-α, MCP-1, and IL-1β in high glucose-induced GMCs. In addition, silencing of JAB1 attenuated the high glucose-induced decrease of superoxide dismutase (SOD) and the increase of reactive oxygen species (ROS) and malondialdehyde (MDA). The increased TGF-β1, collagen I, collagen IV, and fibronectin levels in high glucose-induced GMCs were restored by knockdown of JAB1. Thirdly, angiopoietin-like protein 2 (ANGPTL2) expression was reduced by JAB1. Over-expression of ANGPTL2 weakened the JAB1 silence-induced decrease of IL-6, TNF-α, MCP-1, IL-1β, TGF-β1, collagen I, collagen IV, and fibronectin. In conclusion, silencing of JAB1 reduced extracellular matrix deposition and suppressed inflammation in high glucose-induced GMCs through down-regulation of ANGPTL2.
650    _2
$a angiopoetinu podobný protein 2 $7 D000091302
650    _2
$a angiopoetinu podobné proteiny $x metabolismus $7 D000075802
650    _2
$a kolagen $x metabolismus $7 D003094
650    12
$a diabetické nefropatie $x metabolismus $7 D003928
650    _2
$a extracelulární matrix $x metabolismus $7 D005109
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibronektiny $x metabolismus $7 D005353
650    _2
$a glukosa $x metabolismus $x toxicita $7 D005947
650    _2
$a lidé $7 D006801
650    _2
$a zánět $7 D007249
650    _2
$a interleukin-6 $7 D015850
650    _2
$a mužské pohlaví $7 D008297
650    12
$a mesangiální buňky $x metabolismus $7 D050527
650    _2
$a signální transdukce $7 D015398
650    _2
$a transformující růstový faktor beta1 $x metabolismus $7 D053773
650    _2
$a TNF-alfa $x metabolismus $7 D014409
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wu, Y. $u Department of Endocrinology, Shanghai International Medical Center, Shanghai, China
700    1_
$a Gu, Y. $u Department of Internal Medicine, Shanghai International Medical Center, Shanghai, China
700    1_
$a Li, C. $u Department of General Practice, Shanghai International Medical Center, Shanghai, China
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 67, č. 5-6 (2021), s. 191-198
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35439852 $y Pubmed
856    41
$u https://fb.cuni.cz/file/5964/fb2021a0024.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20220504 $b ABA008
991    __
$a 20220606152936 $b ABA008
999    __
$a ok $b bmc $g 1800787 $s 1164280
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 67 $c 5-6 $d 191-198 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK138 $a Pubmed-20220504

Find record

Citation metrics

Logged in users only

Archiving options